Review: Worldwide lifetime prevalence of anxiety disorders is 16.6%, with considerable heterogeneity between studies - Commentary

Evidence-Based Mental Health

Volumn 9, Issue 4, 2006, Pages 115-

  Starcevic, Vladan ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 57349087463     PISSN: 13620347     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebmh.9.4.115     Document Type: Note

References (3)

1. Robins LN, Regier DA. Psychiatric disorders in America. New York: Macmillan, 1991.
2. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19. (Pubitemid 24028993)
3. Narrow WE, Rae DS, Robins LN, et al. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates. Arch Gen Psychiatry 2002;59:115-23. (Pubitemid 34137378)